Sorah Yoon

USPTO Granted Patents = 10 (Patent Applications = 2)

EPO Patents = 2 (Patent Applications = 5)

Average Co-Inventor Count = 2.8

ph-index = 2

Forward Citations = 6(Granted Patents)

Company Filing History:

where one patent can have more than one assignee

Years Active: 2016-2024

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12138279 - Bi specific aptamer (2024-11-12),

2. 11845938 - Aptamer compositions and the use thereof (2023-12-19),

3. 11427826 - RNA aptamers against transferrin receptor (TfR) (2022-08-30),

4. 11261449 - Anti-cancer RNA aptamers (2022-03-01),

5. 11236341 - RNA aptamers against transferrin receptor (TFR) (2022-02-01),

6. 11225665 - P38 map kinase inhibitors (2022-01-18),

7. 11219635 - Bi-specific aptamer (2022-01-11),

8. 11180761 - PDGFR RNA aptamers (2021-11-23),

9. 10550394 - Anti-cancer RNA aptamers (2020-02-04),

10. 9464293 - RNA aptamers for therapeutic and diagnostic delivery to pancreatic cancer cells (2016-10-11),

Title: The Innovative Contributions of Sorah Yoon in Cancer Research

Introduction

Sorah Yoon, an accomplished inventor based in Pasadena, CA, has made significant strides in the field of cancer research. With a portfolio that includes ten patents, Yoon is recognized for her innovative approaches to targeted cancer therapies. Her work combines cutting-edge technology with a deep understanding of immunology, contributing valuable tools for the fight against cancer.

Latest Patents

Among Sorah Yoon's latest inventions is a bi-specific aptamer, which is specifically designed to bind both a tumor cell antigen and an immune cell surface protein. This invention holds great promise for enhancing the immune response against cancer cells. Additionally, her patent related to aptamer compositions highlights their potential use in cancer treatment, pointing towards new therapeutic avenues that could revolutionize patient care in oncology.

Career Highlights

Throughout her career, Sorah Yoon has actively contributed to leading research institutions. She has worked with notable organizations such as City of Hope, where she focused on developing innovative cancer treatments, and Apterna Limited, which specializes in aptamer technologies. Her dedication to research and development has made her a key figure in the ongoing battle against cancer.

Collaborations

Sorah Yoon has collaborated with esteemed colleagues such as John J Rossi and Nagy Habib. These partnerships have fostered a rich environment for innovation, enabling the rapid development of novel therapeutic approaches. Together, they have paved the way for breakthroughs in cancer research, showcasing the power of collaborative efforts in science.

Conclusion

Sorah Yoon's contributions to cancer research and her impressive array of patents highlight her pivotal role as an inventor and innovator. Through her work, she not only advances scientific knowledge but also creates tangible solutions that could significantly improve patient outcomes. Her career represents a beacon of hope in the ongoing quest for effective cancer therapies.

This text is generated by artificial intelligence and may not be accurate.